Exact Mass: 648.4601

Exact Mass Matches: 648.4601

Found 59 metabolites which its exact mass value is equals to given mass value 648.4601, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DG(15:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

(2S)-1-Hydroxy-3-(pentadecanoyloxy)propan-2-yl (5R,6R,7Z,9Z,11E,13E,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C38H64O8 (648.4601)

DG(15:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/15:0/0:0)

(2S)-3-Hydroxy-2-(pentadecanoyloxy)propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C38H64O8 (648.4601)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(15:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

(2R)-2-Hydroxy-3-(pentadecanoyloxy)propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C38H64O8 (648.4601)

DG(15:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/15:0)

(2S)-2-hydroxy-3-(pentadecanoyloxy)propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoate

C38H64O8 (648.4601)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

(2S)-1-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propan-2-yl (5R,6R,7Z,9Z,11E,13E,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C38H64O8 (648.4601)

DG(a-15:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/a-15:0/0:0)

(2S)-3-Hydroxy-2-[(12-methyltetradecanoyl)oxy]propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C38H64O8 (648.4601)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-15:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

(2R)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C38H64O8 (648.4601)

DG(a-15:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/a-15:0)

(2S)-2-Hydroxy-3-[(12-methyltetradecanoyl)oxy]propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C38H64O8 (648.4601)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)

(2S)-1-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propan-2-yl (5R,6R,7Z,9Z,11E,13E,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C38H64O8 (648.4601)

DG(i-15:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-15:0/0:0)

(2S)-3-Hydroxy-2-[(13-methyltetradecanoyl)oxy]propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C38H64O8 (648.4601)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-15:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

(2R)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C38H64O8 (648.4601)

DG(i-15:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/i-15:0)

(2S)-2-Hydroxy-3-[(13-methyltetradecanoyl)oxy]propyl (5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoic acid

C38H64O8 (648.4601)

DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Karaviloside I

(+)-Karavilagenin A 3-glucoside

C38H64O8 (648.4601)

2-[[(2R)-2-dodecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[(2R)-3-dodecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[(2R)-3-decanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[(2R)-3-decanoyloxy-2-[(E)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[(2R)-3-dodecanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[(2R)-2-dodecanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[(2S)-2-decanoyloxy-3-[(E)-hexadec-7-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[(2S)-2-decanoyloxy-3-[(E)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[hydroxy-[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[hydroxy-[(2S)-3-[(E)-pentadec-9-enoyl]oxy-2-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[(2R)-3-decanoyloxy-2-[(E)-hexadec-7-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[3-dodecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[3-decanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[hydroxy-[3-tridecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[hydroxy-[2-[(Z)-pentadec-9-enoyl]oxy-3-undecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[2-[(Z)-henicos-11-enoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[3-acetyloxy-2-[(Z)-tetracos-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[3-heptanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[3-hexanoyloxy-2-[(Z)-icos-11-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[3-butanoyloxy-2-[(Z)-docos-13-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[[2-[(Z)-heptadec-9-enoyl]oxy-3-nonanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

2-[hydroxy-[2-[(Z)-octadec-9-enoyl]oxy-3-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H67NO8P+ (648.4604)

Heptaprenylglyceryl phosphate

C38H65O6P (648.4519)

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3br,4s,7s,9as,9bs,11ar)-4-methoxy-1-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3br,4s,7s,9as,9bs,11ar)-4-methoxy-1-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C38H64O8 (648.4601)

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3br,4s,7s,9as,9bs,11ar)-4-methoxy-1-[(2r,4s)-4-methoxy-6-methylhept-5-en-2-yl]-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3br,4s,7s,9as,9bs,11ar)-4-methoxy-1-[(2r,4s)-4-methoxy-6-methylhept-5-en-2-yl]-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C38H64O8 (648.4601)

(2r)-2,3-dihydroxypropyl 25-{[(2e)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoyl]oxy}pentacosanoate

C38H64O8 (648.4601)

2-(hydroxymethyl)-6-{[4-methoxy-1-(6-methoxy-6-methylhept-4-en-2-yl)-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

C38H64O8 (648.4601)

2,3-dihydroxypropyl 25-{[3-(3-hydroxy-4-methoxyphenyl)prop-2-enoyl]oxy}pentacosanoate

C38H64O8 (648.4601)

(2r,3r,4r,5s,6r)-2-{[(1r,3as,3br,4r,7s,9as,9bs,11ar)-4-methoxy-1-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4r,5s,6r)-2-{[(1r,3as,3br,4r,7s,9as,9bs,11ar)-4-methoxy-1-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C38H64O8 (648.4601)

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3br,4r,7s,9as,9bs,11ar)-4-methoxy-1-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3br,4r,7s,9as,9bs,11ar)-4-methoxy-1-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C38H64O8 (648.4601)

(2r,3r,4r,5s,6r)-2-{[(1r,3as,3br,4s,7s,9as,9bs,11ar)-4-methoxy-1-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4r,5s,6r)-2-{[(1r,3as,3br,4s,7s,9as,9bs,11ar)-4-methoxy-1-[(2r,4e)-6-methoxy-6-methylhept-4-en-2-yl]-3a,6,6,9b,11a-pentamethyl-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C38H64O8 (648.4601)